Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: UK Stocks Seen Lower On US Sell-Off, Ukraine

Mon, 14th Apr 2014 06:39

LONDON (Alliance News) - UK stocks are set to open firmly lower Monday, following another sharp sell-off on Wall Street on Friday and a weak Asian session overnight, and as increasing tensions in Ukraine are also likely to hurt investor sentiment.

Wall Street continued its recent down trend on Friday as concerns remain about potentially overvalued stocks, particularly in sectors like technology and biotechnology. Concerns first emerged in the tech-heavy NASDAQ Composite index on April 4 and have weighed on global indices ever since.

US stocks closed significantly lower Friday, with the DJIA down 0.9% and the S&P 500 down 1%. The NASDAQ Composite closed down 1.3% at 3,999.734, the first time it has closed below 4,000 since early February.

In Asia, ahead of the UK equity market open, both the Shanghai Composite index and Nikkei in Tokyo are down 0.4%, while the Hang Seng is marginally lower.

"Even if some investors weren?t nervous about the beginning of earnings season before last week, they probably are now, after a poor earnings report from JP Morgan on Friday helped already jittery US markets tip lower still," said Michael Hewson, chief market analyst at CMC Markets.

"Investors aren't likely to get much comfort today with Citigroup the next in line to report and expectations likely to remain low given the banks? troubles with the Federal Reserve and regulators in the past few months," Hewson warned.

The ongoing tensions in Ukraine also are likely to weigh on investor sentiment Monday.

In the latest developments, Ukraine's acting President Oleksandr Turchynov said pro-Russian separatists must lay down their weapons and leave the police stations and administrative buildings they are occupying in eastern Ukraine, or face a large-scale military operation.

"We will not let Russia repeat the Crimean scenario in the eastern regions of Ukraine," Turchynov said.

In an emergency United Nations Security Council meeting late on Sunday, Russia's ambassador to the UN said that the situation was getting out of control, and that "it is the West that will determine the opportunity to avoid civil war in Ukraine".

The US' ambassador, however, accused Russia of inciting instability in Ukraine and spreading disinformation, ""while the Ukrainians are being confronted by incitement and violence".

Ahead of the UK equity market open, both CMC Markets and IG are calling the FTSE 100 to open firmly lower Monday. CMC indicates the blue-chip index will open down at approximately 6,525 points, after it closed at 6,561.7 on Friday, while IG expects it to open at 6,521 points.

UK house prices rose to a record high, according to property tracking website Rightmove Monday. Asking prices increased at a pace of 7.3% year-on-year in April, following a 6.8% rise in March, while the monthly growth held steady at 2.6% in April.

Still ahead in the data calendar, Italian consumer price inflation figures are released at 0800 GMT, ahead of industrial production data for the euro area at 0900 GMT.

In the US, retail sales figures are published at 1230 GMT, before business inventories information at 1400 GMT.

In corporate news, pharmaceutical major GlaxoSmithKline is facing a criminal probe in Poland for allegedly paying bribes to doctors to promote its asthma drug Seretide, BBC Panorama reported on Sunday. According to the report, eleven doctors and one of Glaxo's regional managers have been charged over alleged corruption between 2010 and 2012. Glaxo is already facing corruption accusations in China and Iraq.

Elsewhere, mining company Glencore Xstrata has agreed to sell its interest in the Las Bambas copper project in Peru to a Chinese consortium for USD5.85 billion in cash.

The consortium, which includes MMG Ltd., Guoxin International Investment Corp. Ltd, and CITIC Metal Co. Ltd., will reimburse all capital expenditure and other costs incurred in developing the project between January 1 and the closing date of the deal. Up until the end of March, this was estimated to be around USD400 million.

Meanwhile, Japanese financial services group Orix Corp is considering bidding for FTSE 100-listed Standard Chartered's consumer credit unit in Hong Kong, according to Bloomberg. Standard Chartered wants to sell the unit for about USD700 million, almost three times book value, and plans to compile a shortlist of potential bidders this month, the report said.

By James Kemp; jameskemp@alliancenews.com; @jamespkemp

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.